Mesenchymal Stromal Cells for Cardiovascular Repair: Current Status and Future Challenges
- 3 November 2009
- journal article
- review article
- Published by Taylor & Francis in Future Cardiology
- Vol. 5 (6) , 605-617
Abstract
Ischemic heart disease is the most common cause of death in most industrialized countries. Early treatment with stabilizing drugs and mechanical revascularization by percutaneous coronary intervention or coronary bypass surgery has reduced the mortality significantly. In spite of improved offers of treatments in patients with heart failure, the 1-year mortality is still approximately 20% after the diagnosis has been established. Treatment with stem cells with the potential to regenerate the damaged myocardium is a relatively new approach. Mesenchymal stromal cells are a promising source of stem cells for regenerative therapy. Clinical studies on stem cell therapy for cardiac regeneration have shown significant improvements in ventricular pump function, ventricular remodeling, myocardial perfusion, exercise potential and clinical symptoms compared with conventionally treated control groups. The results of most studies are promising, but there are still many unanswered questions. In this review, we explore present preclinical and clinical knowledge regarding the use of stem cells in cardiovascular regenerative medicine, with special focus on mesenchymal stromal cells. We take a closer look at sources of stem cells, delivery method and methods for tracking injected cells.Keywords
This publication has 105 references indexed in Scilit:
- Repair of Acute Myocardial Infarction by Human Stemness Factors Induced Pluripotent Stem CellsCirculation, 2009
- Induced Pluripotent Stem Cells Generated Without Viral IntegrationScience, 2008
- Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen‐stimulated B‐cell immunoglobulin production in vitroCell Biology International, 2008
- Characterization of adipose tissue-derived cells isolated with the Celution™ systemCytotherapy, 2008
- Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat heartsJournal of Molecular and Cellular Cardiology, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemiaCardiovascular Research, 2005
- Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based TherapiesTissue Engineering, 2001
- Out of Eden: Stem Cells and Their NichesScience, 2000